Uncategorised - European Medical Journal

Eye And Blood Protein Identified as Promising Biomarker for Dementia

SLIT2 protein in eye and blood linked to early cognitive decline, paving the way for new dementia tests.

New Research Shows Promise for Treating Chemoresistant Neuroblastoma

Researchers are making progress in the fight against neuroblastoma (NB), a challenging childhood tumour known for its resistance to chemotherapy.

EADV 2025: Smoking Linked to Greater Severity in HS

In Cohort 1, data from 787 participants revealed that current smokers, who comprised 53.9% of the group, were more likely to present with severe disease.

A traditional row of german houses with a german flag flying from a roof.

Pharma in Germany

The pharma sector in Germany has research, investment and access to medicine to its name, but how can it reclaim its innovation crown?

Collaborative Care: Supporting GPs in Delivering Mental Health

Evidence shows that early GP intervention and continuity of care are linked with fewer hospital admissions and reduced demand for out-of-hours services.

Interview: Susan Manzi

I always say that you have to think of lupus to diagnose it. There are a few facts that may help. Lupus tends to impact young women…

Advancing Liver Care with ESSENTIALE

Unlock expert insights into the evolving landscape of liver health with this interactive symposium video. Focused on the role of…

Chemotherapy Choice Drives Diarrhea Risk in Anal Cancer

Acute diarrhea during chemoradiotherapy for anal cancer is significantly more likely among patients treated with 5-fluorouracil (5-FU) or capecitabine compared with those receiving cisplatin or radiotherapy alone, according to new findings.

Updated Criteria Advance Vascular Dementia Diagnosis

Revised international diagnostic criteria have been introduced for vascular cognitive impairment and dementia (VCID), aiming to standardize assessment and improve consistency across clinical and research settings.

Post-Treatment AFP Levels Predict Liver Cancer Risk in Hepatitis C

Discover a study showing that post-treatment AFP levels help predict hepatocellular carcinoma risk in chronic hepatitis C patients after antiviral therapy.